Medmix
MEDXMEDX · Stock Price
Historical price data
Overview
Medmix is an independent, publicly traded global market leader in high-precision delivery and mixing devices, spun off from Sulzer in 2021. Its mission is to provide innovative solutions that help millions live healthier and more confident lives by serving as a critical B2B partner to OEMs in healthcare, consumer, and industrial markets. The company leverages a deep heritage of engineering, a portfolio of over 900 active patents, and a global footprint of 14 sites to drive growth through innovation and strategic acquisitions.
Technology Platform
An applied engineering platform integrating deep expertise in fluid dynamics, material science, and precision manufacturing to design and mass-produce high-precision mechanical delivery and fluid mixing systems for healthcare, industrial, and consumer applications.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Medmix competes in fragmented markets against specialists in each segment, such as Ypsomed in drug delivery and Nordson in industrial dispensing. Its primary competitive advantages are its cross-market technology platform, global manufacturing scale, deep regulatory expertise, and portfolio of trusted, established brands like Haselmeier and Mixpac.